| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $44.8M | — | -2.6% |
| Cost of Revenue | $10.4M | — | -1.3% |
| R&D Expense | $19.8M | — | +42.8% |
| SG&A Expense | $18.4M | — | +4.7% |
| Operating Income | -$3.8M | — | -196.1% |
| Pre-tax Income | -$3.4M | — | -204.9% |
| Net Income | -$3.8M | — | -226.2% |
| EPS (Basic) | -$0.07 | — | -216.7% |
| EPS (Diluted) | -$0.07 | — | -216.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $36.2M | +22.1% | -42.6% |
| Short-term Investments | $65.4M | -3.7% | +116.8% |
| Accounts Receivable | $26.3M | -50.9% | +4.6% |
| Inventory | $8.7M | +57.6% | -0.7% |
| Current Assets | $142.3M | -12.6% | +7.4% |
| Total Assets | $192.7M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $15.4M | — | +326.8% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | $2.5M | — | +61.6% |
| Financing Cash Flow | -$11.3M | — | +0.0% |
| Free Cash Flow | $15.4M | — | +334.1% |
| -1.8% |
| Current Liabilities | $59.7M | -26.5% | -31.1% |
| Long-term Debt | $11.3M | -50.0% | -80.0% |
| Total Liabilities | $64.3M | -25.2% | -35.1% |
| Stockholders' Equity | $128.4M | -1.5% | +32.2% |